GCC Generic Drug Market Analysis, Industry Share, Size, Growth Rate, Opportunity and Forecast 2022-2027

Request for a sample copy of this report: https://www.imarcgroup.com/gcc-generic-drug-market/requestsample

GCC Generic Drug Industry Trends and Drivers:

An increase in the prevalence of lifestyle and chronic diseases, including diabetes, cancer and obesity, in the GCC region on account of sedentary lifestyles and changing dietary preferences is one of the major factors contributing to the growth of the market. Along with this, the rising geriatric population across the region is another key factor driving the sales of generic drugs as they are more prone to illnesses and health disorders. Moreover, the treatment costs of various diseases using generic medicines are relatively lower than regular brand-name counterparts. The upcoming patent expiry of a number of blockbuster medicines is expected to expand the product portfolio of the manufacturers, thus creating a positive outlook for the market. Furthermore, governments of various GCC countries, such as Oman and the UAE, are promoting the uptake of generic drugs, which is providing a thrust to the market in the region.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on container type, therapeutic area and distribution channel.

Breakup by Container Type:

• Vials
• Prefilled Syringes
• Ampoules
• Premix
• Others
   

Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.

Breakup by Therapeutic Area:

• Oncology
• Anaesthesia
• Anti-infectives
• Cardiovascular
• Parenteral Nutrition
• Others
   

Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.

Breakup by Distribution Channel:

• Hospitals
• Clinics
• Retail Pharmacy Stores
   

These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.

Regional Insights:

• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman
• Bahrain
   

Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.

Competitive Landscape:

The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal